ArticleAntimicrobial agents and chemotherapy2017

Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects.

Erik Mogalian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.